Fig. 7. PTPIP51/HER2/c-Src interactome under selective inhibition of c-Src in SK-BR3 cells.
Interaction of PTPIP51 and c-Src in SK-BR3 cells treated with the indicated concentrations of Dasatinib over 24 h (a). Interaction of PTPIP51 and HER2 in SK-BR3 cells treated with the indicated concentrations of Dasatinib over 24 h (b). Interaction of HER2 and c-Src in SK-BR3 cells treated with the indicated concentrations of Dasatinib over 24 h (c)